craniopharyngioma
Information
- Disease name
- craniopharyngioma
- Disease ID
- DOID:3840
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01419067 | Active, not recruiting | Phase 2 | A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection | August 22, 2011 | July 2026 |
| NCT04937335 | Completed | Craniopharyngioma With Tumoral Hemorrhage | January 1, 2013 | February 1, 2021 | |
| NCT03330080 | Completed | Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients | February 12, 2018 | January 29, 2019 | |
| NCT01206543 | Completed | N/A | 1.5T Intraoperative MR Imaging in Craniopharyngiomas | April 2002 | August 2006 |
| NCT01272622 | Completed | N/A | Prospective Study of Children and Adolescents With Craniopharyngioma | October 2007 | September 30, 2019 |
| NCT01484873 | Completed | Phase 2 | Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor | June 2012 | March 2015 |
| NCT01881854 | Completed | Sleep Wake and Melatonin Pattern in Craniopharyngioma | November 2011 | September 2016 | |
| NCT02063295 | Completed | Phase 2 | An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury | April 2014 | November 2014 |
| NCT02162732 | Completed | N/A | Molecular-Guided Therapy for Childhood Cancer | July 8, 2014 | January 18, 2024 |
| NCT03194906 | Completed | Phase 2 | Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | November 7, 2017 | June 28, 2023 |
| NCT02849743 | Completed | Phase 2 | Intranasal Oxytocin in Hypothalamic Obesity | October 2016 | May 2022 |
| NCT02842723 | Completed | Phase 2 | Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma) | March 2010 | February 2, 2021 |
| NCT06299891 | Not yet recruiting | Phase 2 | Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity | May 1, 2024 | May 31, 2026 |
| NCT02792582 | Recruiting | Phase 2 | A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection | June 22, 2016 | June 2027 |
| NCT05465174 | Recruiting | Phase 2 | Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults | September 12, 2022 | March 1, 2028 |
| NCT05525273 | Recruiting | Phase 2 | Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma | September 1, 2023 | April 10, 2028 |
| NCT06217848 | Recruiting | Early Phase 1 | The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study | November 28, 2022 | March 8, 2024 |
| NCT04087902 | Recruiting | Long-Term Longitudinal QoL in Patients Undergoing EEA | July 16, 2019 | December 31, 2025 | |
| NCT04158284 | Recruiting | Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts | October 1, 2019 | June 30, 2024 | |
| NCT04648462 | Recruiting | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | January 1, 2018 | January 1, 2035 | |
| NCT00840047 | Recruiting | Phase 2 | Methionine PET/CT Studies In Patients With Cancer | July 20, 2009 | July 27, 2027 |
| NCT00949156 | Unknown status | Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma | September 1997 | December 2015 | |
| NCT00517959 | Unknown status | Phase 3 | SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors | May 2001 | June 2017 |
| NCT03708913 | Withdrawn | N/A | Neuromodulation for Hypothalamic Obesity | June 1, 2019 | April 1, 2020 |
- Disase is a (Disease Ontology)
- DOID:0060090
- Cross Reference ID (Disease Ontology)
- GARD:10486
- Cross Reference ID (Disease Ontology)
- ICDO:9350/1
- Cross Reference ID (Disease Ontology)
- MESH:D003397
- Cross Reference ID (Disease Ontology)
- NCI:C2964
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:189179009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0010276
- Exact Synonym (Disease Ontology)
- neoplasm of Rathke's Pouch
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030062
- OrphaNumber from OrphaNet (Orphanet)
- 54595
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003397